stock.name

Insulet Corporation

PODD

Market Cap$12.14B
Close$

Compare Insulet

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Insulet CorporationInsulet Corporation58.90%28%7.71.9
marketMarket Avg58.21.29%31%-1
HealthcareHealthcare Avg641.3%15%-0.9
$226.00

Target Price by Analysts

22.6% upsideInsulet Target Price DetailsTarget Price
$-73.00

Current Fair Value

139.6% downside

Overvalued by 139.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.14 Billion
Enterprise Value$12.85 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$2.8
Beta1.11
Outstanding Shares70,022,493
Avg 30 Day Volume699,679

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio58.86
PEG11.6
Price to Sales7.68
Price to Book Ratio18.43
Enterprise Value to Revenue7.57
Enterprise Value to EBIT58.43
Enterprise Value to Net Income62
Total Debt to Enterprise0.11
Debt to Equity1.93

Revenue Sources

No data

ESG Score

No data

About Insulet Corporation

CEO: Shacey Petrovic